Literature DB >> 15627790

Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis.

Filippo Aucella1, Patrizia De Bonis, Giuseppe Gatta, Lucia Anna Muscarella, Mimmo Vigilante, Giuseppe di Giorgio, Michele D'Errico, Leopoldo Zelante, Carmine Stallone, Luigi Bisceglia.   

Abstract

BACKGROUND: Mutations in the NPHS2 gene, encoding podocin, and in the ACTN4 gene, encoding alpha-actinin-4, have been identified in familial childhood-onset forms of focal and segmental glomerulosclerosis (FSGS). NPHS2 may be also responsible for some sporadic cases. The role of NPHS2 and ACTN4 in the adult sporadic form of the disease is being clarifying.
METHODS: Thirty-three adult subjects affected by sporadic FSGS were studied at molecular level. At biopsy, 12 patients had nephrotic syndrome, 5 patients had isolated proteinuria and 16 patients showed proteinuria and hematuria. Glomerular filtration rate (GFR) was in the normal range in 19 subjects and 14 patients had a variable degree of renal failure. Multiplex families presenting with a clear familial inheritance for proteinuria or other congenital nephrotic syndrome were excluded. The whole coding region, all intron/exon boundaries and flanking intronic regions of NPHS2 gene and the exon 8, i.e. hot-spot mutations of the ACTN4 gene, were analyzed in all patients by denaturing high-performance liquid chromatography (DHPLC) to search disease-causing defects.
RESULTS: The analysis identified four already described and two new polymorphisms, IVS3-21C>T and IVS3-46C>T, on the NPHS2 gene. Moreover, the R229Q allele was identified in 3/33 patients and in 7/124 controls, accounting for an allelic frequency of 0.045 and 0.028, respectively. The new intronic polymorphism IVS7-54C>T was also found in the exon 8 of the ACTN4 gene.
CONCLUSIONS: In this study, we exhaustively analyzed the NPHS2 and the exon 8 of the ACTN4 genes in a series of sporadic 'adult-onset' FSGS patients. No causative mutations were found while the R229Q allele was identified in 3 patients confirming its possible role as a 'disease-associated NPHS2 allele' although its pathogenetic involvement needs to be further clarified. Moreover, the description of new intronic polymorphisms in both genes is reported. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627790     DOI: 10.1159/000082864

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  10 in total

1.  Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.

Authors:  Sheila Santín; Gemma Bullich; Bárbara Tazón-Vega; Rafael García-Maset; Isabel Giménez; Irene Silva; Patricia Ruíz; José Ballarín; Roser Torra; Elisabet Ars
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

2.  The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis.

Authors:  Lu Lu; Heng Wan; Yi Yin; Wen-Jun Feng; Ming Wang; Yu-Cong Zou; Bo Huang; Dong-Tao Wang; Yin Shi; Yan Zhao; Lian-Bo Wei
Journal:  Int Urol Nephrol       Date:  2014-04-09       Impact factor: 2.370

3.  Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.

Authors:  Sheila Santín; Bárbara Tazón-Vega; Irene Silva; María Ángeles Cobo; Isabel Giménez; Patricia Ruíz; Rafael García-Maset; José Ballarín; Roser Torra; Elisabet Ars
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 8.237

4.  Super-Resolution Imaging of the Filtration Barrier Suggests a Role for Podocin R229Q in Genetic Predisposition to Glomerular Disease.

Authors:  Linus Butt; David Unnersjö-Jess; Martin Höhne; Robert Hahnfeldt; Dervla Reilly; Markus M Rinschen; Ingo Plagmann; Paul Diefenhardt; Sebastian Brähler; Paul T Brinkkötter; Hjalmar Brismar; Hans Blom; Bernhard Schermer; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2021-12-01       Impact factor: 10.121

5.  Relevance of the ACTN4 gene in African-Americans with non-diabetic end-stage renal disease.

Authors:  Meredith A Bostrom; Peter Perlegas; Lingyi Lu; Pamela J Hicks; Greg Hawkins; Maggie C Y Ng; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Am J Nephrol       Date:  2012-09-04       Impact factor: 3.754

6.  NPHS2 variation in focal and segmental glomerulosclerosis.

Authors:  Stephen J Tonna; Alexander Needham; Krishna Polu; Andrea Uscinski; Gerald B Appel; Ronald J Falk; Avi Katz; Salah Al-Waheeb; Bernard S Kaplan; George Jerums; Judy Savige; Jennifer Harmon; Kang Zhang; Gary C Curhan; Martin R Pollak
Journal:  BMC Nephrol       Date:  2008-09-29       Impact factor: 2.388

7.  Association Between NPHS2 p.R229Q and Focal Segmental Glomerular Sclerosis/Steroid-Resistant Nephrotic Syndrome.

Authors:  Qiongxiu Zhou; Qinjie Weng; Xiaoyan Zhang; Yunzi Liu; Jun Tong; Xu Hao; Hao Shi; Pingyan Shen; Hong Ren; Jingyuan Xie; Nan Chen
Journal:  Front Med (Lausanne)       Date:  2022-07-22

8.  Genetics of focal segmental glomerulosclerosis.

Authors:  Robert P Woroniecki; Jeffrey B Kopp
Journal:  Pediatr Nephrol       Date:  2007-03-09       Impact factor: 3.714

9.  Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06

10.  Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults.

Authors:  Nicola Lepori; Ladan Zand; Sanjeev Sethi; Gema Fernandez-Juarez; Fernando C Fervenza
Journal:  Clin Kidney J       Date:  2018-01-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.